Search clinical trials for: Programmed cell death protein-1 antibody
Total 102148 results
-
Daniela Matei, MDMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkCompletedEndometrial Cancer | Endometrial AdenocarcinomaUnited States
-
Ondokuz Mayıs UniversityCompletedPeriodontitis | Osteoporosis, Postmenopausal
-
Groupe Français de Pneumo-CancérologieCompleted
-
PDL BioPharma, Inc.Unknown
-
Second Affiliated Hospital, School of Medicine,...Zhejiang Cancer Hospital; Sun Yat-sen University; Ningbo Medical Center Lihuili... and other collaboratorsRecruitingPlaque, Atherosclerotic | Programmed Cell Death Protein 1 InhibitorChina
-
Eastern Mediterranean UniversityEge UniversityCompletedPolymorphism, Restriction Fragment Length | Irisin | Uncoupling Protein-1Turkey
-
Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Australia, Canada, Chile, China, France, Greece, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, South Africa, Spain, Sweden
-
Lung Therapeutics, IncCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Henan Cancer HospitalFundamenta Therapeutics, Ltd.Not yet recruitingAllogeneic, CAR-T, Protein Sequestration, Non-gene EditedChina
-
Lawson Health Research InstituteCompleted
-
PfizerWithdrawnBladder CancerPoland, United States
-
Prof. Dr. med. Andreas F. H. PfeifferEuropean UnionCompleted
-
Janssen Vaccines & Prevention B.V.Completed
-
Anglia Ruskin UniversityDanone Nutricia ResearchRecruitingGastrointestinal Dysfunction | Amino Acid ChangeUnited Kingdom
-
Mark Garzotto, MDMerck Sharp & Dohme LLC; Astellas Pharma IncRecruitingProstate CancerUnited States
-
Walter Reed Army Medical CenterEastern Virginia Medical School; University of Virginia; James Madison UniversityCompletedTear Protein Lacritin in Human TearsUnited States
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central HospitalWithdrawn
-
Fudan UniversityInnovent Biologics (Suzhou) Co. Ltd.Not yet recruitingEsophageal Squamous Cell CarcinomaChina
-
Thomas Jefferson UniversityCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedPharmacokinetics | Advanced Malignancies | Solid Malignancies | Protein Kinase Inhibitors | Maximum Tolerated Dose | Antineoplastic Protocols | Clinical Trial, Phase 1
-
University of California, Los AngelesCompletedPrediabetic StateUnited States
-
Shanghai Zhongshan HospitalActive, not recruitingCholangiocarcinoma, IntrahepaticChina
-
Akdeniz UniversityCompletedPeriodontitis | Gingival Crevicular Fluid | Interleukin 1-beta | Bactericidal Permeability ProteinTurkey
-
Shanghai Zhongshan HospitalShenzhen University General Hospital; Xuhui Central Hospital, Shanghai; Minhang... and other collaboratorsRecruitingCholangiocarcinoma, IntrahepaticChina
-
BeiGeneRecruitingMSI-H/dMMR Solid TumorsChina
-
Bristol-Myers SquibbCompleted
-
Protein Supplies SLCompleted
-
Protein Sciences CorporationCompletedInfluenzaUnited States
-
Protein Sciences CorporationCompleted
-
Protein Sciences CorporationCompleted
-
Rhythm Pharmaceuticals, Inc.CompletedPro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene MutationsUnited States, Israel, Canada, Germany, Greece, Italy, Portugal
-
Hengenix Biotech IncSanyou Biopharmaceuticals(Shanghai)Co., Ltd; Shanghai ZJ Bio-Tech Co., LtdWithdrawn
-
McMaster UniversityCompletedOlder Adults | Muscle Protein Synthetic Response to Protein | Reduced Physical ActivityCanada
-
TC Erciyes UniversityNot yet recruitingPOCD - Postoperative Cognitive Dysfunction | Mechanical Bowel Preparation
-
Nutricia ResearchCompletedColorectal Cancer | Lung CancerNorway, Netherlands, Belgium, Lithuania, Estonia, Poland, Portugal
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
Institut National de la Recherche AgronomiqueAgroParisTechUnknown
-
Incyte CorporationBristol-Myers SquibbTerminated
-
Washington University School of MedicineBASFCompleted
-
Ludwig Institute for Cancer ResearchCompletedProstate CancerSwitzerland, Germany
-
Tufts Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingHeart Failure | Muscle AtrophyUnited States
-
Sun Yat-sen UniversityRecruitingMuscle-Invasive Bladder Carcinoma | Radiotherapy | Programmed Cell Death Protein 1 InhibitorChina
-
Shanghai Zhongshan HospitalActive, not recruiting
-
Sun Yat-sen UniversityRecruitingLiver Diseases | Hepatocellular Carcinoma | Immunotherapy | Camrelizumab | LenvatinibChina
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
The Central Hospital of Lishui CityThe First Affiliated Hospital of Zhengzhou University; Jiangxi Provincial Cancer... and other collaboratorsNot yet recruitingCarcinoma, Non-Small-Cell Lung
-
Induce Biologics USA Inc.Enrolling by invitation
-
Protein Supplies SLCompleted
-
Denver Health and Hospital AuthorityMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.Completed